胰腺导管腺癌的诊断与治疗建议。波兰胰腺俱乐部工作组的建议
Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club.
作者信息
Winter Katarzyna, Talar-Wojnarowska Renata, Dąbrowski Andrzej, Degowska Małgorzata, Durlik Marek, Gąsiorowska Anita, Głuszek Stanisław, Jurkowska Grażyna, Kaczka Aleksandra, Lampe Paweł, Marek Tomasz, Nasierowska-Guttmejer Anna, Nowakowska-Duława Ewa, Rydzewska Grażyna, Strzelczyk Janusz, Śledziński Zbigniew, Małecka-Panas Ewa
机构信息
Department of Digestive Tract Diseases, Medical University of Lodz, Lodz, Poland.
Department of Gastroenterology and Internal Medicine, Medical University of Bialystok, Bialystok, Poland.
出版信息
Prz Gastroenterol. 2019;14(1):1-18. doi: 10.5114/pg.2019.83422. Epub 2019 Mar 12.
Abstract
These recommendations refer to the current management in pancreatic ductal adenocarcinoma (PDAC), a neoplasia characterised by an aggressive course and extremely poor prognosis. The recommendations regard diagnosis, surgical, adjuvant and palliative treatment, with consideration given to endoscopic and surgical methods. A vast majority of the statements are based on data obtained in clinical studies and experts' recommendations on PDAC management, including the following guidelines: International Association of Pancreatology/European Pancreatic Club (IAP/EPC), American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), National Comprehensive Cancer Network (NCCN) and Polish Society of Gastroenterology (PSG) and The National Institute for Health and Care Excellence (NICE) All recommendations were voted on by members of the Working Group of the Polish Pancreatic Club. Results of the voting and brief comments are provided with each recommendation.
摘要
这些建议涉及胰腺导管腺癌（PDAC）的当前管理，这是一种具有侵袭性病程和极差预后特征的肿瘤。这些建议涵盖诊断、手术、辅助和姑息治疗，并考虑了内镜和手术方法。绝大多数陈述基于临床研究获得的数据以及专家关于PDAC管理的建议，包括以下指南：国际胰腺病协会/欧洲胰腺俱乐部（IAP/EPC）、美国临床肿瘤学会（ASCO）、欧洲医学肿瘤学会（ESMO）、美国国立综合癌症网络（NCCN）、波兰胃肠病学会（PSG）以及英国国家卫生与临床优化研究所（NICE）。所有建议均由波兰胰腺俱乐部工作组的成员投票表决。每项建议都附有投票结果和简要评论。
相似文献
1
Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club.胰腺导管腺癌的诊断与治疗建议。波兰胰腺俱乐部工作组的建议
Prz Gastroenterol. 2019;14(1):1-18. doi: 10.5114/pg.2019.83422. Epub 2019 Mar 12.
2
Diagnostic and therapeutic recommendations for chronic pancreatitis. Recommendations of the Working Group of the Polish Society of Gastroenterology and the Polish Pancreas Club.慢性胰腺炎的诊断与治疗建议。波兰胃肠病学会和波兰胰腺俱乐部工作组的建议。
Prz Gastroenterol. 2018;13(3):167-181. doi: 10.5114/pg.2018.78067. Epub 2018 Sep 17.
3
Diagnostics and Treatment of Thyroid Carcinoma.甲状腺癌的诊断与治疗
Endokrynol Pol. 2016;67(1):74-107. doi: 10.5603/EP.2016.0011.
4
International consensus statements on early chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with The International Association of Pancreatology, American Pancreatic Association, Japan Pancreas Society, PancreasFest Working Group and European Pancreatic Club.关于早期慢性胰腺炎的国际共识声明。慢性胰腺炎国际共识指南工作组与国际胰腺病协会、美国胰腺协会、日本胰腺学会、胰腺节工作组和欧洲胰腺俱乐部合作提出的建议。
Pancreatology. 2018 Jul;18(5):516-527. doi: 10.1016/j.pan.2018.05.008. Epub 2018 May 21.
5
Levels of Evidence Supporting United States Guidelines in Pancreatic Adenocarcinoma Treatment.支持美国胰腺癌治疗指南的证据水平
Cancers (Basel). 2022 Aug 22;14(16):4062. doi: 10.3390/cancers14164062.
6
International Consensus Guidelines for Risk Factors in Chronic Pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club.国际慢性胰腺炎危险因素共识指南。本指南由协作制定国际慢性胰腺炎共识指南的工作组成员、国际胰腺病学会、美国胰腺学会、日本胰腺学会和欧洲胰腺俱乐部共同推荐。
Pancreatology. 2020 Jun;20(4):579-585. doi: 10.1016/j.pan.2020.03.014. Epub 2020 Apr 8.
7
Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.溃疡性结肠炎管理指南。波兰胃肠病学会及波兰国家胃肠病学顾问的建议。
Prz Gastroenterol. 2023;18(1):1-42. doi: 10.5114/pg.2023.125882. Epub 2023 Mar 15.
8
Management of acute pancreatitis (AP) - Polish Pancreatic Club recommendations.急性胰腺炎（AP）的管理——波兰胰腺俱乐部建议
Prz Gastroenterol. 2016;11(2):65-72. doi: 10.5114/pg.2016.60251. Epub 2016 Jun 8.
9
Guidelines for the management of patients with Crohn's disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.克罗恩病患者管理指南。波兰胃肠病学会及波兰国家胃肠病学顾问的建议。
Prz Gastroenterol. 2021;16(4):257-296. doi: 10.5114/pg.2021.110914. Epub 2021 Nov 19.
10
Do the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology Magnitude of Clinical Benefit Scale Measure the Same Construct of Clinical Benefit?美国临床肿瘤学会价值框架和欧洲肿瘤内科学会临床获益幅度量表是否衡量相同的临床获益构建？
J Clin Oncol. 2017 Aug 20;35(24):2764-2771. doi: 10.1200/JCO.2016.71.6894. Epub 2017 Jun 2.
引用本文的文献
1
Synaptophysin-like-1: A Novel Serum Diagnostic Marker for Pancreatic Ductal Adenocarcinoma Screening, Early Diagnosis, and Prognosis Prediction.突触素样蛋白-1：一种用于胰腺导管腺癌筛查、早期诊断及预后预测的新型血清诊断标志物。
J Clin Med. 2025 May 26;14(11):3719. doi: 10.3390/jcm14113719.
2
Changes Connected to Early Chronic Pancreatitis and Early Pancreatic Cancer in Endoscopic Ultrasonography (EUS): Clinical Implications.内镜超声检查（EUS）中与早期慢性胰腺炎和早期胰腺癌相关的变化：临床意义
Cancers (Basel). 2025 Jun 5;17(11):1891. doi: 10.3390/cancers17111891.
3
Select Endocrine Disorders and Exosomes in Early PDAC Diagnosis.选择内分泌紊乱和外泌体在早期 PDAC 诊断中的应用。
Int J Mol Sci. 2024 Nov 13;25(22):12159. doi: 10.3390/ijms252212159.
4
Robust and consistent biomarker candidates identification by a machine learning approach applied to pancreatic ductal adenocarcinoma metastasis.通过机器学习方法识别胰腺导管腺癌转移的稳健且一致的生物标志物候选物。
BMC Med Inform Decis Mak. 2024 Jun 20;24(Suppl 4):175. doi: 10.1186/s12911-024-02578-0.
5
A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present.求生之路：胰腺癌早期生物标志物综述及目前最有效的方法。
Biomolecules. 2024 Mar 19;14(3):364. doi: 10.3390/biom14030364.
6
Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors.可改变的胰腺导管腺癌（PDAC）风险因素。
J Clin Med. 2023 Jun 27;12(13):4318. doi: 10.3390/jcm12134318.
7
Real-Life Results of Palliative Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma.转移性胰腺导管腺癌姑息化疗的实际疗效
Cancers (Basel). 2023 Jul 5;15(13):3500. doi: 10.3390/cancers15133500.
8
CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation.糖类抗原19-9而非胰岛素样生长因子-1/胰岛素样生长因子结合蛋白-2是区分胰腺导管腺癌（PDAC）和慢性胰腺炎（CP）的有用生物标志物。
J Clin Med. 2023 Jun 14;12(12):4050. doi: 10.3390/jcm12124050.
9
Endoscopic ultrasound-guided fine-needle aspiration pancreatic adenocarcinoma samples yield adequate DNA for next-generation sequencing: A cohort analysis.内镜超声引导下细针抽吸胰腺腺癌样本可提供足够的 DNA 用于下一代测序：一项队列分析。
World J Gastroenterol. 2023 May 14;29(18):2864-2874. doi: 10.3748/wjg.v29.i18.2864.
10
The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions.PET/MRI在胰腺恶性病变患者临床管理中的进展
Front Oncol. 2023 Apr 28;13:920896. doi: 10.3389/fonc.2023.920896. eCollection 2023.
本文引用的文献
1
Diagnostic and therapeutic recommendations for chronic pancreatitis. Recommendations of the Working Group of the Polish Society of Gastroenterology and the Polish Pancreas Club.慢性胰腺炎的诊断与治疗建议。波兰胃肠病学会和波兰胰腺俱乐部工作组的建议。
Prz Gastroenterol. 2018;13(3):167-181. doi: 10.5114/pg.2018.78067. Epub 2018 Sep 17.
2
Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence.成人胰腺导管腺癌的诊断与管理：英国国家卫生与保健卓越研究所指南摘要
Pancreatology. 2018 Dec;18(8):962-970. doi: 10.1016/j.pan.2018.09.012. Epub 2018 Sep 28.
3
Diagnosis and Management of Exocrine Pancreatic Insufficiency.外分泌性胰腺功能不全的诊断与管理
Curr Treat Options Gastroenterol. 2018 Sep;16(3):306-315. doi: 10.1007/s11938-018-0186-y.
4
Challenges in diagnosis of pancreatic cancer.胰腺癌诊断的挑战。
World J Gastroenterol. 2018 May 21;24(19):2047-2060. doi: 10.3748/wjg.v24.i19.2047.
5
Surgical treatment of pancreatic cancer.胰腺癌的外科治疗
Pol Przegl Chir. 2018 Apr 30;90(2):45-53. doi: 10.5604/01.3001.0011.7493.
6
Advanced pancreatic cancer: a meta-analysis of clinical trials over thirty years.晚期胰腺癌：一项超过三十年临床试验的荟萃分析。
Oncotarget. 2018 Apr 10;9(27):19396-19405. doi: 10.18632/oncotarget.25036.
7
Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy.辅助放化疗可改善接受手术治疗的胰腺腺癌患者的生存：在调强放疗时代，单独辅助化疗是不够的。
Cancer Med. 2018 Jun;7(6):2328-2338. doi: 10.1002/cam4.1479. Epub 2018 Apr 17.
8
EUS-guided biliary drainage: A comprehensive review of the literature.超声内镜引导下胆道引流：文献综述
Endosc Ultrasound. 2018 Jan-Feb;7(1):4-9. doi: 10.4103/eus.eus_105_17.
9
Diagnostic yield of EUS-FNA of small (≤15 mm) solid pancreatic lesions using a 25-gauge needle.超声内镜引导下细针抽吸活检术对直径≤15mm 胰腺实性小病灶的诊断价值。
Hepatobiliary Pancreat Dis Int. 2018 Feb;17(1):70-74. doi: 10.1016/j.hbpd.2018.01.010. Epub 2018 Jan 31.
10
Imaging for pancreatic ductal adenocarcinoma.胰腺导管腺癌的影像学检查
Chin Clin Oncol. 2017 Dec;6(6):62. doi: 10.21037/cco.2017.11.03.
Zotero 插件